|
BioHealth and Life Sciences Update - 2/21/17
|
|
Gain Visibility for Your Firm at BIO 2017 in San Diego
|
Don't need a booth? Use a
video/logo* scrolling on
screens to promote your
firm in the pavilion.
*Visibility options $250-$8K.
|
|
BioHealth and Life Sciences News
|
|
|
Gaithersburg's NexImmune acquired by a consortium of private investors led by former Celgene and Medtronic CEOs.
Baltimore's Personal Genome Diagnostics awarded National Cancer Institute contract to develop novel diagnostic for Immuno-Oncology drugs.
Rockville's OncoImmune raises $15M to develop its novel clinical stage asset targeting the CD24-Siglec pathway that regulates host inflammatory response to tissue injuries.
Germantown's Intrexon agrees to buy Gaithersburg-based Genvec to expand Intrexon's proprietary industry-leading gene delivery platform.
Rockville's Supernus announces issuance of Seventh and Eighth patents for Trokendi XR®.
Baltimore's Surgigyne licenses innovative laparoscopic surgical device technology from UMB and closes a seed round of funding from UM Ventures and a private investor.
Rockville's REGENXBIO announces IND Active for Phase I Trial of RGX-314 to treat wet age-related Macular Degeneration.
Gaithersburg's Novavax initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in older adults.
Germantown's Neuralstem announces last subject enrolled in Phase 2 Trial with NSI-189 for Major Depressive Disorder. This Phase 2 data now is expected in 3Q 2017.
Baltimore's Cerecor seeks to raise $12M to further develop its psychiatric drugs CERC-501 and CERC-611 focused on assisting patients with neurological and psychiatric disorders.
Gaithersburg's MagBio Genomics launches new Blood STASISTM 21-ccfDNA tube for venous whole blood collection and room temperature stabilization of circulating cell-free DNA.
Cambridge's Convergene is working with UMB to evaluate leading anti-cancer agents, and with NCATS to commercialize jointly developed small molecule BET bromodomain inhibitors.
Gaithersburg's Emergent BioSolutions receives BARDA task order valued at up to $30.5M develop viral hemorrhagic fever therapeutics. The company also has initiated a NIAID-Funded Phase 1b Clinical Study to Evaluate Broad-Spectrum Antiviral UV-4B for Dengue.
Bethesda's Brainscope announces results of clinical trial validating the clinical efficacy of its Ahead 300 technology for the identification of TBI in mildly presenting head injured patients.
Germantown's Epigenomics announces two publications affirming high sensitivity and specificity for its blood-based FDA approved Epi proColon test.
Silver Spring's Repar Corporation develops unique biochemical substance Maintain® CF 125 for Pineapple. It also is used for the control of pollen and fruit on ornamental olives/citrus.
Annapolis Junction is now the US headquarters location of INFORS HT, the Swiss manufacturer of bioreactors, shaking incubations and bioprocess software solutions.
|
|
Upcoming Deadlines and Events
|
ABL, Inc. (Rockville)
To view more job opportunities, MD COMMERCE
Well Doc (Columbia) |
|
Nation's Largest, Most Advanced Mobile STEM Lab Unveiled in MD
|
Gov. Larry Hogan and DLLR Secretary Schulz recently joined MdBio and Maryland business leaders for a ribbon cutting to launch the nation's largest, most advanced mobile STEM lab, " MXLab". Learn more about this new MdBio lab which will be used to promote enhanced classroom learning and support workforce development throughout Maryland. Sign up now for the MXLab Open House, March 7, 2017, 4:00-6:00PM.
|
|
The Maryland Department of Commerce focuses on attracting, retaining, and expanding businesses and creating jobs in Maryland, and also markets Maryland's many assets to companies across the nation and abroad.
The Department's Office of BioHealth and Life Sciences supports innovative start-ups and companies focused on animal and human health, health IT, research tools, and related technologies. These include those involving agricultural and marine bio, biodefense, therapeutics, vaccines, diagnostics, medical devices, biologics, nutraceuticals, personalized and regenerative medicine, digital health, mHealth, telemedicine, EHR, bioinformatics, data center services, patient engagement, and wellness.
|
|
|
|
|
